Replies to post #10460 on BioSante Pharmaceuticals, Inc. (BPAX)

[starbuxsux]

BPAX

Teva Reports Fourth Quarter and Full Year 2011 Results

Fourth Quarter Net Revenues Total $5.7 Billion, up 28%, with Non-GAAP EPS of $1.59, up 27%

Full Year 2011 Net Revenues Total $18.3 Billion, up 14%, with Non-GAAP EPS of $4.97, up 9%

25% Increase in Quarterly Dividend to NIS 1.00 Per Share